233 related articles for article (PubMed ID: 27136302)
21. A pathogenic fungi diphenyl ether phytotoxin targets plant enoyl (acyl carrier protein) reductase.
Dayan FE; Ferreira D; Wang YH; Khan IA; McInroy JA; Pan Z
Plant Physiol; 2008 Jul; 147(3):1062-71. PubMed ID: 18467464
[TBL] [Abstract][Full Text] [Related]
22. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN
J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968
[TBL] [Abstract][Full Text] [Related]
23. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase.
Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286
[TBL] [Abstract][Full Text] [Related]
24. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors.
da Silva Lima CH; de Alencastro RB; Kaiser CR; de Souza MV; Rodrigues CR; Albuquerque MG
Int J Mol Sci; 2015 Oct; 16(10):23695-722. PubMed ID: 26457706
[TBL] [Abstract][Full Text] [Related]
25. High-resolution structures of Thermus thermophilus enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan.
Otero JM; Noël AJ; Guardado-Calvo P; Llamas-Saiz AL; Wende W; Schierling B; Pingoud A; van Raaij MJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1139-48. PubMed ID: 23027736
[TBL] [Abstract][Full Text] [Related]
26. Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity.
Lu H; England K; am Ende C; Truglio JJ; Luckner S; Reddy BG; Marlenee NL; Knudson SE; Knudson DL; Bowen RA; Kisker C; Slayden RA; Tonge PJ
ACS Chem Biol; 2009 Mar; 4(3):221-31. PubMed ID: 19206187
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
[TBL] [Abstract][Full Text] [Related]
28. Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
Afanador GA; Muench SP; McPhillie M; Fomovska A; Schön A; Zhou Y; Cheng G; Stec J; Freundlich JS; Shieh HM; Anderson JW; Jacobus DP; Fidock DA; Kozikowski AP; Fishwick CW; Rice DW; Freire E; McLeod R; Prigge ST
Biochemistry; 2013 Dec; 52(51):9155-66. PubMed ID: 24295325
[TBL] [Abstract][Full Text] [Related]
29. Ligand- and Structure-Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence.
Kronenberger T; de Oliveira Fernades P; Drumond Franco I; Poso A; Gonçalves Maltarollo V
ChemMedChem; 2019 Dec; 14(23):1995-2004. PubMed ID: 31670463
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
Inturi B; Pujar GV; Purohit MN
Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.
Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A
Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852
[TBL] [Abstract][Full Text] [Related]
32. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases.
Muralidharan J; Suguna K; Surolia A; Surolia N
J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
Kini SG; Bhat A; Pan Z; Dayan FE
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
[TBL] [Abstract][Full Text] [Related]
34. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
Mehboob S; Truong K; Santarsiero BD; Johnson ME
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
[TBL] [Abstract][Full Text] [Related]
35. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
Rana P; Ghouse SM; Akunuri R; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2020 Dec; 208():112757. PubMed ID: 32883635
[TBL] [Abstract][Full Text] [Related]
36. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
37. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
Muench SP; Prigge ST; McLeod R; Rafferty JB; Kirisits MJ; Roberts CW; Mui EJ; Rice DW
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):328-38. PubMed ID: 17327670
[TBL] [Abstract][Full Text] [Related]
38. Structural and Biochemical Studies on Klebsiella Pneumoniae Enoyl-ACP Reductase (FabI) Suggest Flexible Substrate Binding Site.
Biswas S; Patra A; Paul P; Misra N; Kushwaha GS; Suar M
Protein J; 2024 Feb; 43(1):84-95. PubMed ID: 38127182
[TBL] [Abstract][Full Text] [Related]
39. Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).
Lu X; Huang K; You Q
Expert Opin Ther Pat; 2011 Jul; 21(7):1007-22. PubMed ID: 21651455
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan.
Lee HH; Moon J; Suh SW
Proteins; 2007 Nov; 69(3):691-4. PubMed ID: 17879346
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
